Deloitte & Touche v Livent Inc (Receiver of)

Allkem and Livent Announce Board of Directors for New TopCo

Retrieved on: 
Wednesday, August 2, 2023

Allkem Chair Peter Coleman commented "We are pleased to announce the new Board of Directors for the merged company.

Key Points: 
  • Allkem Chair Peter Coleman commented "We are pleased to announce the new Board of Directors for the merged company.
  • "I would also like to acknowledge both Richard and Martin who will be retiring as directors following completion of the Transaction.
  • We are grateful for their experience, leadership, and collaboration on the Livent board and for all of the contributions they have made in getting Livent to its current position."
  • The amendment to the Transaction Agreement reflects the decision that the New TopCo Board as of the closing of the Transaction will now comprise 12 members, instead of the previously contemplated 14 members, consisting of six directors nominated by Allkem and six directors nominated by Livent.

Mesirow CEO Natalie A. Brown named one of the Most Influential Women Executives in Corporate America

Retrieved on: 
Monday, November 28, 2022

Mesirow CEO named to inaugural list of the Most Influential Women Executives in Corporate America by WomenInc.

Key Points: 
  • Mesirow CEO named to inaugural list of the Most Influential Women Executives in Corporate America by WomenInc.
  • 's list features women executives, influencers and achievers impacting corporate America in its fall issue.
  • is proud to present the 2022 Most Influential Women Executives in Corporate America.
  • Selection of the Most Influential Women Executives in Corporate America begins with more than 500 prospective candidates in diverse fields.

DGAP-News: Immunic Receives Notice of Allowance for Composition-of-Matter Patents in the United States and in Europe for IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor

Retrieved on: 
Wednesday, February 2, 2022

Immunic Receives Notice of Allowance for Composition-of-Matter Patents in the United States and in Europe for IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor

Key Points: 
  • Immunic Receives Notice of Allowance for Composition-of-Matter Patents in the United States and in Europe for IMU-935, a Potentially Best-in-Class Oral IL-17 Inhibitor
    The issuer is solely responsible for the content of this announcement.
  • The company also received notice of allowance of patent application EP18762111.5 in Europe, and notice of grant of patent application 2018330633 in Australia.
  • "We believe IMU-935 is a highly potent and selective oral inhibitor of IL-17, which so far, has shown a remarkably differentiated safety and tolerability profile.
  • Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this press release.

AGM Group Holdings, Inc. Announces Changes in Management

Retrieved on: 
Tuesday, September 28, 2021

Mr. Zhihe Yang tendered his resignation as the Chief Financial Officer ofAGMGroup Holdings Inc. (the "Company"), effective September 23, 2021.

Key Points: 
  • Mr. Zhihe Yang tendered his resignation as the Chief Financial Officer ofAGMGroup Holdings Inc. (the "Company"), effective September 23, 2021.
  • Mr. Yang's resignation as director is not the result of any disagreement with the Company's operations, policies or procedures.
  • Mr. Steven Yuan Ning Sim, age 44,has over 15 years of audit and financial management experience.
  • These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements.